Stents liberadores de drogas: ¿hasta dónde ha llegado la evidencia clínica?
Barra lateral del artículo
Contenido principal del artículo
Resumen
.
##plugins.themes.bootstrap3.displayStats.downloads##
Detalles del artículo
Sección
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Cómo citar
Referencias
sousa Je, costa MA, Abizaid Ac, et al. sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. circulation. 2001;104(17):2007-11.
Morice Mc, serruys PW, sousa Je, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. n engl J Med. 2002;346(23):1773-80
schofer J, schlüter M, gershlick AH, et al. sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (e-si Rius). lancet. 2003;362(9390):1093-9
stone gW, ellis sg, cannon l, et al. comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent inpatients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005;294(10):1215-23.
Dawkins KD, grube e, guagliumi g, et al. clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. circulation. 2005;112(21):3306-13.
liu J, Maehara A, Mintz gs, et al. An integrated tAXus iv, v, and vi intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents. Am J cardiol. 2009;103(4):501-6.
teirstein Ps, Moses JW, leon MB, et al. use of the sirolimus-eluting Bx velOcitytm stent for failed brachytherapy in recurrent in-stent restenosis: results from the secuRe registry. circulation. 2003;108(suppl iv): iv-409. Abstract 1889.
Hayasi B. lAcyR Registry: one year results [internet]. course on revascularization. 2005 mayo ; Paris, Francia. [citado 29/07/09]. Disponible en: http://www.europcronline.com/fo/lecture/view_slide.php?id=2427&start=19
Abizaid A, chan c, Kaul u, et al. "Real world" evaluation of slow-release, polymer-based, paclitaxel-eluting tAXus™ stents in native coronary arteries: the WisDOM international registry. circulation. 2003;108(suppl iv): iv-534. Abstract 2436.
colombo A. the si Rius Bifurcation study. American Heart Association scientific Meeting. 2002 Oct; chicago, usA.
Jiménez-Quevedo P, sabaté M, Angiolillo DJ, et al. long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DiABetes trial. eur Heart J. 2007;28(16):1946-52.
serruys PW, Daemen J, Morice M-c, et al. three-year follow-up of the ARts-ii –sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. eurointervention. 2008;3(4):450-9
Kastrati A, Mehilli J, von Beckerath n, et al. sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA. 2005;293(2):165-71.
Mehili J. A comparison of cypher and taxus drug eluting stents in left main stenosis (is AR-lM). transcatheter cardiovascular therapeutic.. 2008 Oct.
Morice Mc, colombo A, Meier B, et al. sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the ReAlity trial: a randomized controlled trial. JAMA. 2006;295(8):895-904
Duda sH, Bosiers M, lammer J, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the si ROccO trial. J endovasc ther. 2006;13(6):701-10.
camenzind e, steg Pg, Wijns W. stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. circulation. 2007;115(11):1440-55.
stone gW, Moses JW, ellis sg, et al. safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents nengl J Med. 2007;356(10):998-1008.
Kirtane AJ, gupta A, iyengar s, et al. Drug-eluting stent versus bare-metal stent use: meta-analysis of randomized trials and observational studies. circulation 2008;118(s):1040